|
Policosanol in patients with pre-hypertension or with grade I hypertension |
30/06/2021 |
CPN |
|
Policosanol + aspirin in post-stroke cognitive impairment |
30/06/2021 |
CPN |
|
Rectal ozone therapy in high-risk symptomatic SARS-CoV-2 positive patients |
15/07/2021 |
CPN |
|
Efficacy and safety of the Dermatological Soap with ozonized sunflower oil (AGO) and Cream with AGO in patients with Acne. |
15/04/2024 |
CPN |
|
Efficacy and safety of the Dermatological Soap with ozonated sunflower oil (AGO) and Anti-inflammatory Alcohol Cream in patients with chronic Dermatitis. |
15/04/2024 |
CPN |
|
Efficacy and safety of the Dermatological Soap with ozonated sunflower oil (AGO), or with sulfur, or with sulfur+AGO and Cream with AGO in patients with Scabies. |
16/04/2024 |
CPN |
|
Evaluation of the effectiveness of video games for attention intervention in school age boys and girls |
15/03/2023 |
CNEURO |
|
Cuban uterine manipulator, new device for the hysterectomy totally laparoscopic. |
10/02/2017 |
CNCMA |
|
Moringa in Diabetes |
02/11/2021 |
CIPPPB |
|
iorEPOCIM-Stroke-Phase I |
2012-09-17 |
CIMAB |
|
Nimotuzumab for the treatment of high grade of malignancy tumors |
2013-02-01 |
CIMAB |
|
NeuroEPO-Stroke. Phase I-II |
11/09/2014 |
CIMAB |
|
NeuroEPO – Type 2 Spinocerebellar Ataxia Phase I-II |
02/11/2014 |
CIMAB |
|
188Re-marked Ior C5 MAb in persistent or relapsing ovary epithelial cancer, phase I. |
2010-12-27 |
CIM |
|
Nimotuzumab in the treatment of patients with acute respiratory difficulty syndrome (ARDS) |
03/03/2023 |
CIM |
|
Vaccine HER1 / VSSP for prostate cancer, head and neck carcinoma and advanced colon cancer . Phase I |
03/11/2017 |
CIM |
|
14F7 in chronic B-cell lymphoproliferative syndrome |
07/03/2018 |
CIM |
|
NGcGM3/VSSP and nimotuzumab in patients with triple negative breast cancer |
12/10/2016 |
CIM |
|
Itolizumab for Relapsing Remitting Multiple Sclerosis |
22/05/2015 |
CIM |
|
Itolizumab for Moderate-to-Severe Psoriasis-phase 3 |
08/10/2015 |
CIM |
